Stereotaxis announced on January 27, 2025, that it received European CE Mark approval for its MAGiC™ ablation catheter. This approval is a significant milestone for the company and for the community of physicians pioneering robotics in electrophysiology, reflecting Stereotaxis' commitment to advancing innovations in interventional medicine.
The MAGiC catheter is a robotically-navigated magnetic ablation catheter specifically designed to perform cardiac ablation procedures for treating heart arrhythmias. Its development incorporated insights from nearly 20 years and 150,000 robotic ablation procedures, aiming to enhance treatment precision and control while maintaining the intrinsic safety of a soft, flexible catheter.
Obtaining the CE Mark follows years of substantial investments in catheter development, testing, manufacturing, and clinical research. This approval allows Stereotaxis to introduce the MAGiC catheter to European physicians and patients, positioning it as a key pillar in making robotics broadly impactful and beneficial in electrophysiology and endovascular surgery.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.